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Abstract
Loss-of-function mutations in DJ-1 (PARK7) gene account for about 1% of all familial Parkinson’s disease (PD). While its
physiological function(s) are not completely clear, DJ-1 protects neurons against oxidative stress in both in vitro and in vivo
models of PD. The molecular mechanism(s) through which DJ-1 alleviates oxidative stress-mediated damage remains
elusive. In this study, we identified Paraoxonase-2 (PON2) as an interacting target of DJ-1. PON2 activity is elevated in
response to oxidative stress and DJ-1 is crucial for this response. Importantly, we showed that PON2 deficiency
hypersensitizes neurons to oxidative stress induced by MPP+ (1-methyl-4-phenylpyridinium). Conversely, over-expression of
PON2 protects neurons in this death paradigm. Interestingly, PON2 effectively rescues DJ-1 deficiency-mediated
hypersensitivity to oxidative stress. Taken together, our data suggest a model by which DJ-1 exerts its antioxidant
activities, at least partly through regulation of PON2.
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Introduction
PD is a progressive neurodegenerative disorder characterized by
selective loss of the pigmented dopaminergic neurons of the
Substantia nigra pars compacta (SNc) [1], and reduction in striatal
dopamine level. The majority of PD cases do not follow a genetic
inheritance pattern [2]. However, rare familial forms of this
disease with their causative genes have been identified [3,4,5,6].
DJ-1 was identified as one of these PD-related genes [7]. It was
first identified as an oncogene and associated with fertility factors
[8,9]. However, recent evidence in several families showed linkage
of homozygous loss of function mutations in DJ-1 to early onset
PD [7,10]. The mechanisms by which loss of DJ-1 function
promotes PD are unclear. However, it has been most associated
with management of reactive oxygen species (ROS). For example,
our previous data demonstrated that DJ-1 null mice are
hypersensitive to dopaminergic toxin, 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP) [11]. Consistent with this, numerous
reports utilizing in vitro and in vivo models in both mammalian
and drosophila systems support the idea that DJ-1 plays a
neuroprotective role under pathological conditions where oxida-
tive stress predominates [12,13,14,15,16,17,18,19]. How DJ-1
may regulate ROS is not completely clear. DJ-1 is oxidized on its
cysteine residues which are also critical for the ability of DJ-1 to
manage ROS [20]. DJ-1 also possesses atypical peroxiredoxin
activity, although this activity is weak compared to other
antioxidant enzymes [21]. Others have demonstrated that DJ-1
somehow regulates Nrf2, a master transcription factor for a variety
of antioxidant enzymes [22]. However, whether this is true in
neurons is controversial [23].
Recently, to further examine the underlying mechanism(s) by
which DJ-1 exerts protection, we performed a proteomics
interaction screen for DJ-1 interacting partners. By mass
spectrometric analyses, we identified Paraoxonase-2 (PON2) as a
novel interacting candidate for DJ-1 [24]. PON2 is a member of
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Paraoxonase family of genes (Paraoxonase-1, 2, 3), which are
located as a cluster on chromosome 7 in human and chromosome
6 in mouse. PON2 is ubiquitously expressed in a wide variety of
tissues and localized in cytoplasm and membranous structures,
such as plasma membrane [25], endoplasmic reticulum [26], and
mitochondria [27]. Several in vitro and in vivo studies indicate a
role for PON2 in diminishing oxidative stress [25,28,29,30,31].
For example, PON2 deficient HeLa cells exhibit elevated
intracellular oxidative level which can be reversed by over-
expression of PON2 [25]. PON2 deficiency in mice increases the
risk of oxidative stress-related pathophysiological conditions such
as development of atherosclerotic lesions [27,28]. Furthermore,
numerous studies on several human populations reported the
association of PON2 polymorphisms with severe ischemic stroke
[32], sporadic amyotrophic lateral sclerosis (SALS) [33,34,35],
asthma [36] and Alzheimer’s disease (AD) [37,38]. Polymorphisms
in another PON member, PON1, have also been associated with
susceptibility to PD [39,40]. However, the role of PON2 in the
context of neuronal loss induced by oxidative stress is unknown.
Given the initial interaction data from our proteomics screen,
we examined whether DJ-1 may modulate susceptibility to
oxidative stress through regulation of the PON2 enzyme. We
provide evidence that DJ-1 interacts with and promotes PON2
activity in the presence of oxidative stress and that this mechanism
is one central mechanism by which DJ-1 promotes survival.
Methods
Ethics statement
All animal-related experiments were performed based on the
protocols provided by the Canadian Council on Animal Care
(CCAC), the Canadian Institutes of Health Research, and the
University of Ottawa Animal Care and Veterinary Services
(ACVS). This study was approved by University of Ottawa
Animal Care Committee (ACC). All steps of animal welfare,
maintenance, and medical care were also performed by University
of Ottawa ACVS.
In the present study, mice were not subjected to any experiment
while alive and we ensure that they did not suffer during the
process of sacrifice. In order to sacrifice the mice to extract cells or
tissues for in vitro experiments, they were first injected intraper-
itoneally with Euthanyl, then, after confirming they are not awake,
they were subjected to cervical dislocation.
Proteomic screen
The original proteomic screen, utilized to obtain DJ-1
interacting proteins, was published previously [24]. Briefly,
approximately 16107 of human embryonic kidney 293
(HEK293) cells (approximately 40% confluent) were transiently
transfected by calcium phosphate/DNA co-precipitation method,
where calcium chloride were mixed with the target gene-
expressing plasmid and then diluted with an inorganic phosphate
buffer. The calcium phosphate/DNA precipitate was then
incubated with the cells at 37uC for 12–16 hours. Cells were then
cultured in fresh medium (Dulbecco’s modified Eagle’s medium
(DMEM) +10% fetal bovine serum (FBS)) for further 24 hours.
Cells were then scraped and lysed by lysis buffer (20 mM Tris–
HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.5%
sodium deoxycholate, 10 mg/ml aprotinin, 0.2 mM AEBSF
(Calbiochem)), and cleared from cell debris by centrifugation at
20000 g for 30 min. Cleared cell lysate, containing FLAG-tagged
target protein was exposed to M2-Agarose resin (Sigma-
Aldrich)(the monoclonal anti-Flag M2 antibody covalently bound
to agarose resin) for 1 hour, and the precipitated immune
complexes (target protein and its interacting proteins) were eluted
by 50 mM ammonium bicarbonate, containing 400 mM Flag
peptide. The purified protein complexes were subjected to SDS-
PAGE, detected by colloidal Coomassie staining, and protein
bands from qualified lanes were excised from the gel. These
proteins were treated with DTT, iodoacetamide (to alkylate the
free sulfhydryl groups) and trypsin, and the produced peptides
were then purified from the gel and concentraded and analyzed by
mass spectrometry. As reported earlier [24], the data was
generated using an LCQ Deca mass spectrometer (Thermo
Finnigan). Mascot version 1.9 (Matrix Sciences, www.
matrixscience.com) was used to analyze the obtained spectra by
searching against a human protein sequence database with 122989
entries. This database was generated utilizing the main sources of
human protein sequences including GenBank, TrEMBL, Swis-
sProt, IPI, Ensembl. The settings to run the Mascot were as
follows: search mode: MS/MS Ion, fixed modification: carbami-
domethyl on cysteine, variable modification: oxidation on
methionine, peptide mass tolerance: 2 Da, fragment mass
tolerance: 0.4 Da, maximum missed cleavages: 2, enzyme: trypsin.
The Mascot score is the probability of randomness of the match,
and is reported as -10LOG10(P), where P is the absolute
probability. In other word, the score of 30 means the absolute
probability of 1023.
Cortical neuron culture
Cortical neuron cultures were prepared as described before
[41,42]. Briefly, embryos were extracted at 14.5–15.5 days
gestation. Their cortices were dissected and incubated with
0.50 mg/ml trypsin with shaking for 20 minutes at 37uC in
Hank’s balanced salt solution. Trypsinization was stopped with
0.2 mg/ml trypsin inhibitor and 0.2 mg/ml DNaseI at room
temperature. Cells were spun down at 150xg and triturated in
Neurobasal medium containing 0.2 mg/ml trypsin inhibitor and
0.25 mg/ml DNaseI. Cells were pelleted and resuspended in
Neurobasal medium containing B-27 and N-2 supplements and
0.5 mM glutamine. Cells were then plated in dishes pre-coated
with poly-D-lysine.
PON2 deficient and DJ-1 KO mouse embryonic
fibroblasts (MEFs) culture
To culture MEFs, mouse embryos were extracted at 14.5–15.5
days of gestation, their skin was dissected and cut into smaller
pieces in Hank’s balanced salt solution, and incubated in 0.5 mg/
ml trypsin for 60 minutes at 37uC. Trypsinization was stopped
with 0.2 mg/ml trypsin inhibitor and 0.2 mg/ml DNaseI. Cells
were spun down at 150xg, triturated, resuspended, and cultured in
DMEM medium with 10% FBS.
GST pull down assay, immunoprecipitation (IP) and
immunoblotting
Samples (HEK293 cells for IP of over-expressed proteins and
primary cortical neurons for IP of endogenous proteins) were
washed with phosphate buffered saline (PBS) and harvested and
lysed in lysis buffer (50 mM Tris HCl pH 7.5, 100 mM NaCl,
1 mM EDTA, 1 mM DTT, 0.2% NP-40 and protease inhibitor).
Lysate was cleared of cell debris with centrifugation at 17000xg for
20 minutes and supernatant was used for IP. In the case of GST
pull down assay in cells expressing GST-DJ-1, cleared cell lysate
was incubated with 50 ml glutathione sepharose for 2–4 hours. In
other cases, cell lysate was incubated with 4 mg of Myc antibody
(Santa Cruz Biotechnology) or DJ-1 antibody (Abcam) overnight
and with TrueBlot IgG beads (eBiosciences) for 2 hours.
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Precipitated complexes were washed 3 times with lysis buffer and
eluted by boiling in 2x SDS-loading buffer. Proteins were
separated on 10% SDS-polyacrylamide gel and transferred to
nitrocellulose membrane. The membrane was blocked with 1%
milk for 1 hour at room temperature and treated with primary
antibody overnight to probe the target protein. Membrane was
washed 3 times and treated with TrueBlot secondary antibody (to
avoid IgG signal) for 1 hour. Primary antibodies used for Western
blot analyses are: DJ-1 (Abcam), Myc (Santa Cruz Biotechnology),
PON2 (GenScript), b-actin (Sigma).
Membrane extraction and paraoxonase-2 activity using
3-oxo-C12-homoserine lacton
Cells were homogenized in homogenization buffer (5 mM Tris/
HCl pH 7.4, 1 mM CaCl2 and EDTA-free protease inhibitor).
Homogenized cells were pelleted at 17000xg for 30 minutes,
resuspended in extraction buffer (25 mM Tris/HCl pH 7.4,
1 mM CaCl2, 10% glycerol, 1% w/v dodecyl-b-d-maltoside
(DDM) (Sigma-Aldrich Chemicals) and EDTA-free protease
inhibitor (Roche)) and incubated at 4uC with agitation overnight
for complete resuspension. Cell debris was extracted with
centrifuging at 2000xg for 5 min. For PON2 activity, 4 mg of
crude membrane extracts prepared from cultured cortical neurons
or murine embryonic fibroblasts (MEFs) was incubated with
10 mM 3-oxo-C12-homoserine lactone (C12) (Vertex Pharmaceu-
ticals) in a 50 ml volume of 25 mM Tris-HCl, pH 7.4, and 1 mM
CaCl2 at room temperature. Reactions were stopped with an
equal volume of acetonitrile, and 5 ml was used to measure C12 by
quantitative autoinducer bioassay using E.coli MG4 containing
pKDT17 (provided by E. Greenberg, University of Iowa), [22].
The P. aeruginosa lasB gene is activated with 3-oxo-C12-
homoserine lacton (C12). E.coli MG4 containing a plasmid with
lasB::lacZ transcriptional fusion (pKDT17), can be induced by
C12 to activate Beta-galactosidase gene. Beta-galactosidase will
then hydrolyze ortho-Nitrophenyl-b-galactoside (ONPG) to ortho-
nitrophenol with yellow color. The more C12 remaining in the
buffer, the more signal will be produced by beta-galactosidase
activity. For this assay, E.coli MG4 (pKDT17) was divided to 1 ml
aliquots. 0.01 ml of membrane samples (already treated with C12)
was added to each aliquot and incubated for 4 hours at 37uC.
0.1 ml of the culture was added to 1 ml of Z buffer (60 mM
Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4,
50 mM beta-mercaptoethanol) and vortexed for 10 seconds.
0.1 ml of the mixture was transferred to a 96 well plate in
triplicates and Z buffer only was used as blank. 0.02 ml of ONPG
was added to each well and incubated for 10 minutes at room
temperature. Reaction was stopped with 0.05 ml of 1 M Na2CO3
and ONPG signal was read at 420 nm. [43,44,45,46].
PON2 activity using Dihydrocoumarin as a substrate
Intact cells were washed with PBS and incubated with activity
buffer (50 mM Tris-HCl pH 7.4, 1 mM CaCl2 and 1 mM
Dihydrocumarin (DHC) (Sigma-Aldrich Chemicals) as substrate)
at room temperature. UV absorbance at 270 nm was measured
after 10 minutes incubation. One unit of PON2 activity is equal to
1 mmol DHC hydrolyzed/ml/min [47].
In vitro Adenoviral gene delivery, MPP+ treatment and
survival assessment
Adenovirus vector expressing DJ-1 was produced in house by
subcloning the cDNA of WT DJ-1 into pAdTRACK vector,
where the expression of GFP and DJ-1 is controlled by
independent cytomegalovirus promoters. Adenovirus was pro-
duced and titered as described before [48]. Adenovirus vector
expressing PON2 was kindly provided by Dr. Srinivasa Reddy
(UCLA), where it was also generated by subcloning WT human
PON2 cDNA into pAdTRACK vector [49]. Adenoviral infection
was performed at the time of plating, at a multiplicity of infection
(MOI) of 30 for survival experiments and MOI of 100 for
biochemical analyses. For survival assays, 48 hours after plating,
the cultures were treated with 20 mM of MPP+ (Sigma-Aldrich
Chemicals) for 48 hours as previously described [50,51]. Cultures
were then fixed with 4% Paraformaldehyde (PFA), washed 2 times
with PBS and stained with Hoechst 33258 (0.5 ng/ml). The
percentage of surviving neurons was calculated as the number of
GFP-positive neurons with intact nucleus over the total number of
GFP-positive neurons [52]. For survival assays with no adenoviral
infection, primary cortical neurons obtained from PON2 deficient
or wild type mice were subjected to 10, 20 and 40 mM MPP+
treatment for 48 hours. Cells were lysed and the survival rate was
assessed by direct microscopy and counting intact nuclei.
Statistical analysis
Statistical significance was assessed by Anova and post-hoc test
Tukey on data obtained from three independent experiments. All
data are presented as mean 6 SEM, and significance is marked by
* in case of p,0.05, ** in case of p,0.01 and *** in case of p,
0.001.
Results
DJ-1 interacts with PON2
We previously reported a systems biological approach to
generation of a large scale human protein-protein interaction
map as a tool for understanding proteins functions and the
mechanisms of disease [24]. This map was generated based upon a
screen utilizing a large number of human bait proteins (407 unique
bait proteins) mostly known for their role in diseases such as breast
cancer, colon cancer, diabetes and obesity. These bait proteins
were used to immunoprecipitate potential interacting partners
subsequently identified through mass spectrometric analyses.
Our original data set was filtered with a number of criteria
designed to eliminate false positive and non specific interactions
which eliminated a large number of valid potential interactors.
These exclusion criteria included targets which appeared to
interact with more than 5% of bait proteins. Accordingly, we
reanalyzed our data sets with focus on DJ-1 eliminating these
exclusion criteria. We further analyzed DJ-1 interacting candidates
with proper biochemical interaction studies to further validate any
potential hits obtained through our systems biology directed
screen.
In this study we report the identification and characterization of
a new DJ-1 interacting partner, Paraoxonase-2 (PON2). We
initially identified DJ-1 through peptide analyses using PON2 as
bait (mascot score 30.2, Figure 1A). We next confirmed the
interaction of DJ-1 and PON2 in HEK293 cells. The initial
experiments were performed utilizing expressed DJ-1. Plasmids
expressing GST-DJ-1 were transfected into HEK293 cells and
analyses performed by affinity precipitating with glutathione
sepharose beads and Western blot analyses for endogenous
PON2, utilizing a PON2 antibody. In figure 1B, we show that
expression of GST-DJ-1 but not a GST control plasmid
immunoprecipitates PON2. The reciprocal experiment was also
performed, HEK293 cells were transfected with a vector
expressing Myc-PON2 (M-PON2). PON2 was immunoprecipitat-
ed with a Myc antibody and immunoblotted for endogenous DJ-1
utilizing a DJ-1 antibody (Figure 1C). In figure 1C, we show that
Protective Role of DJ-1 through Paraoxonase-2
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immunoprecipitation with Myc antibody but not IgG control
antibody reveals interaction of PON2 with DJ-1. Finally, we tested
whether both endogenous PON2 and DJ-1 interact in neurons.
We carried out co-immunoprecipitation-Western blot assay using
cultured murine cortical neurons. Endogenous DJ-1 was immu-
noprecipitated with DJ-1 antibody and immunoblotted with
PON2 antibody. As shown in figure 1D, PON2 was co-
immunoprecipitated with DJ-1 antibody but not with IgG control
antibody. Taken together, this indicates that PON2 associates with
DJ-1 in vivo.
Effects of DJ-1 and oxidative stress on PON2 activity
Previous reports have shown that PON2 lactonase activity
increases in response to oxidative stress [53]. Given that DJ-1
interacts with PON2, we hypothesized that DJ-1 modulates PON2
activity in this paradigm. To test this hypothesis, we measured
PON2 lactonase activity in cortical neurons derived from DJ-1
wild-type (WT) or knockout (KO) embryos treated with MPP+
(20 mM), for 12 hours. MPP+ is a complex I inhibitor which leads
to oxidative stress and death of a number of different neurons
[54,55,56,57,58]. PON2 lactonase activity was first measured by
assessing the percentage of hydrolysis of PON2 specific substrate,
3-oxo-C12-homoserine lactone (C12) by PON2 [28]. As shown in
figure 2A, PON2 activity is significantly elevated after MPP+
treatment in wild-type neurons. Remarkably, DJ-1 deficiency not
only blocked PON2 basal lactonase activity, but also blocked
MPP+-induced enzymatic activity. We then confirmed this result
using a second assay protocol which involves hydrolysis of
dihydrocoumarin (DHC), a lactone which can be hydrolyzed by
PON2 [47,53,59]. Similarly, with this assay, oxidative stress
induced PON2 activity only in WT neurons and not in DJ-1
deficient neurons (Figure 2B). To further confirm this observation,
we measured hydrolysis of DHC in another cell type challenged
with a different oxidative reagent. Indeed, PON2 activity was also
elevated in response to oxidative stress induced by hydrogen
peroxide (100 mM for 24 hours) in WT murine embryonic
fibroblasts (MEFs) but not in DJ-1 KO MEFs (Figure 2C). This
supports the idea that DJ-1 regulates PON2 activity in multiple
cellular contexts and ROS conditions. Finally, we determined
whether low PON2 activity observed under conditions of DJ-1
deficiency could be rescued by DJ-1 expression. Accordingly, we
expressed DJ-1 or GFP in DJ-1 WT or KO MEFs (Figure 2D).
DJ-1 KO MEFs expressing GFP have less PON2 activity
measured by C12. This activity in DJ-1 KO MEFS expressing
DJ-1 increases by almost 59%. Taken together, these results
indicate that loss of DJ-1 impairs PON2 activity and that this loss
can be rescued by DJ-1 re-expression.
Importantly, we also determined the effects of DJ-1 expression
in PON2 deficient (PON2 def) cells. We expressed DJ-1 or GFP as
control in PON2 WT or deficient MEFs (Figure 3B), and PON2
activity was measured as described above. As shown in figure 3A,
DJ-1 expression in PON2 WT MEFs induced PON2 activity by
almost 51% compared to GFP control group. However, the
induced activity observed in PON2 deficient MEFs was dramat-
ically lower (less than 5%). The small amount of background
lactonase activity observed in PON2 deficient cells may be the
contribution of other PON members [60,61,62,63,64,65], or the
fact that PON2-def mice are reported to having up to 5% of
leakiness based on the mouse construction method [66], although
this is unclear at the moment. These results indicate that the
lactonase activity induced by DJ-1 is almost exclusively through
PON2.
DJ-1 does not affect PON2 protein level in neurons
DJ-1 is reported to interact with RNA and/or localize to the
nucleus [67,68]. Accordingly, it is possible that DJ-1 acts through
regulation of transcription/translation/stabilization of PON2 and
that direct interaction demonstrated above, is not necessary for the
modulation of PON2 by DJ-1. To examine this possibility, we
treated cortical neurons obtained from DJ-1 WT or KO embryos
with MPP+ (20 mM) for 0, 6, 12 and 24 hours and compared their
PON2 protein levels using western blot analysis. Our data
demonstrates that there is no significant difference in PON2
protein level between DJ-1 WT and KO neurons. In addition,
Figure 1. DJ-1 and PON2 interact. (A) DJ-1 full length protein sequence. Peptide observed from DJ-1 after using PON2 as bait is highlighted.
Mascot peptide score is 30.2. (B) HEK293 cells expressing GST-DJ-1 or GST as control were lysed and GST-DJ-1 was precipitated by glutathione
sepharose beads and analyzed with Western blotting using PON2 antibody. (C) HEK293 cells were transfected with plasmid expressing Myc-PON2 (M-
PON2). Cells were lysed and Myc-PON2 was precipitated with Myc antibody. Isolated complexes were analyzed with Western blotting using DJ-1
antibody. (D) DJ-1 was pulled down by DJ-1 antibody from cell lysate extracted from cultured cortical neurons. Immune complexes were analyzed
with Western blotting using PON2 antibody.
doi:10.1371/journal.pone.0106601.g001
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PON2 protein level does not change in response to MPP+ induced
oxidative stress (Figure 3C). This observation rules out the
possibility that DJ-1 increases PON2 activity through increasing
PON2 protein levels.
PON2 protects against MPP+-induced neuronal death
Loss of DJ-1 results in hypersensitization to a number of death-
inducing oxidative stress stimuli. If the regulation of PON2 by DJ-
1 is biologically significant we would anticipate that a) PON2 loss
would also sensitize neurons to oxidative stress and b) PON2
expression would rescue the sensitization to stress induced by loss
of DJ-1. This would also suggest PON2 as a downstream target of
DJ-1. To test this hypothesis, we first treated PON2 WT or
deficient cortical neurons with 0, 10, 20 and 40 mM MPP+ for
48 hours and assessed the neuronal cell survival by nuclear
integrity. Our data shows that PON2 deficient neurons are
significantly hypersensitive to MPP+ treatment when compared to
neurons from WT littermate controls (Figure 4A). To confirm the
protective function of PON2, we expressed Myc-PON2 along with
GFP, or GFP alone as control in WT or PON2 def cortical
neurons. The cells were exposed to 20 mMMPP+ for 48 hours and
their survival was assessed by counting proportion of GFP positive
cells with intact nuclei to total GFP positive cells, as described
previously [11]. Our data demonstrate that PON2 expression
rescues PON2 deficiency-mediated hypersensitivity to MPP+
(Figure 4B). Finally, we examined whether PON2 expression can
also rescue DJ-1 loss-mediated hypersensitivity to MPP+. To test
this, we expressed PON2 and GFP, or GFP alone as control by
adenoviral infection in DJ-1 WT or KO cortical neurons. After
treatment with MPP+ (20 mM) for 48 hours, the cell survival was
assessed as above. Consistent with our hypothesis, PON2
expression protects neurons against MPP+ and can also reverse
the hypersensitivity observed with DJ-1 loss (Figure 4C).
Discussion
Several studies have demonstrated the link between DJ-1 and
oxidative damage in neurodegeneration [11,12,13,18,19,69]. The
purpose of the present study was to investigate the mechanism(s)
underlying the capacity of DJ-1 to mediate survival. In an initial
Figure 2. DJ-1 and oxidative stress modulate PON2 activity. (A) Cultured WT and DJ-1 KO cortical neurons were treated with MPP+ (20 mM)
for 12 hours and cells were washed and membrane was extracted. Crude membrane was exposed to the substrate C12 for 60 minutes and the
percentage of remaining C12 was measured. (B) Cultured WT and DJ-1 KO cortical neurons were treated with MPP+ (20 mM) for 24 hours. Neurons
were then exposed to DHC for 10 minutes and the amount of hydrolysis of DHC was assessed with measuring UV absorbance. One unit of PON2
activity is equal to 1 mmol DHC hydrolyzed/ml/min. (C) WT and DJ-1 KO MEFs were treated with hydrogen peroxide (100 mM) for 24 hours and PON2
activity was measured as described in B. (D) WT and DJ-1 KO MEFs were infected with adenovirus expressing DJ-1 or GFP alone as control. After
48 hours of expression, cells were lysed and exposed to C12 as the substrate for 60 minutes. Percentage of C12 remaining in activity buffer was
measured. Statistical significance was assessed by Anova and post-hoc test Tukey on data obtained from three independent experiments (n = 3). *
denotes p,0.05, ** denotes p,0.01, and *** denotes p,0.001.
doi:10.1371/journal.pone.0106601.g002
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mass spectrometry screen for DJ-1 interacting protein, we
identified PON2 as a candidate interacting partner. We confirmed
this interaction, particularly under endogenous conditions in
primary neurons. The model by which DJ-1 is a critical factor in
regulating PON2 activity is supported by several observations.
First, elevated PON2 activity which occurs in response to MPP+
mediated oxidative stress is dependent upon DJ-1. Multiple cell
types including neurons and MEFs have lowered PON2 activity in
the absence of DJ-1 in response to oxidative stress. This deficiency
can be rescued by DJ-1 expression. Importantly, our results also
suggest that manner by which DJ-1 regulates PON2 is not through
more potentially indirect effects on PON2 stability since DJ-1
deficiency has no effect on PON2 levels. The manner by which
DJ-1 regulates PON2 activity is unclear. Our interaction data
between DJ-1 and PON2 suggest that direct or indirect binding of
the two proteins may be important. However, this must be
confirmed by additional studies which rely on identifying the
interaction domains between DJ-1 and PON2. Whatever the
mechanism, our data clearly shows the importance of DJ-1 in
regulating PON2 lactonase activity.
Second, we show that PON2 itself is critical for regulating
survival in response to conditions of oxidative stress (in particular
induced by MPP+). Neurons deficient in PON2 are more sensitive
to MPP+ treatment which can be rescued by re-introduction of
PON2. These results are consistent with the notion that PON2 is
known to lower ROS [25,28,29,70]. Interestingly, DJ-1 deficient
neurons are also similarly hypersensitive to oxidative stress and this
hypersensitivity can be reversed by PON2 expression. This
observation is consistent with the model by which DJ-1 acts to
increase the activity of PON2. Note that while these observations
imply that DJ-1 is a critical regulator of PON2, it is not an absolute
requirement for PON2 activity. Finally, even though our data
suggest that PON2 is one important factor in the protective effects
of DJ-1, we do not imply that it is the only factor. In this regard,
we recently also identified VHL as an additional DJ-1 interacting
factor[71]. Accordingly, DJ-1 may work through multiple proteins
for its survival functions.
The mechanism by which PON2 lactonase activity relates to
reduced oxidative stress is unclear. One possibility is that the
lactonase activity per se is essential for regulation of death and
oxidative stress. Multiple lines of evidence have shown that
environmental factors such as pesticide exposure can increase the
risk of early onset of Parkinson’s disease [72,73,74]. Paraoxon is an
organophosphorus compounds, active metabolite of the insecticide
parathion, whose toxicity is due to their strong anticholinesterase
action. Evidence has shown that paraoxon can cause apoptotic cell
death in proliferating cells through activation of mitochondrial
pathways [75]. Paraoxon-induced AChE inhibition can aggravate
Figure 3. DJ-1 has no lactonase activity and no effects on PON2 protein level. (A) WT and PON2 deficient MEFs were infected with
adenovirus expressing DJ-1 or GFP. PON2 activity was then measured using C12 as described before. (B) Samples used in panel A was exposed to
SDS-PAGE analysis to assess their levels of DJ-1, PON2 and GFP. (C) Cultured cortical neurons extracted from DJ-1 WT and DJ-1 KO were treated with
MPP+ (20 mM) for different durations. Cells were lysed and PON2 protein level was assessed by western blotting. Statistical significance was assessed
by Anova and post-hoc test Tukey on data obtained from three independent experiments (n = 3). * denotes p,0.05, **denotes p,0.01 and ***
denotes p,0.001.
doi:10.1371/journal.pone.0106601.g003
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Figure 4. PON2 protects neurons against MPP+. (A) Primary cortical neurons obtained from PON2 deficient or wild type mice were subjected to
10, 20 and 40 mM MPP+ treatment for 48 hours. Cells were lysed and viability was assessed by direct microscopy and counting intact nuclei. (B) WT
and PON2 def cortical neurons were transfected with plasmid expressing Myc-PON2 and GFP (under independent promoters), or GFP as control, and
subjected to 20 mM MPP+ for 48 hours. Cells were fixed and the nuclei were stained with Hoechst. Survival percentage represents the ratio of GFP-
expressing cells with morphologically intact nuclei (D, a and b) to the total number of GFP positive cells. (C) WT and DJ-1 KO cortical neurons over-
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experimental Parkinsonism triggered by MPTP in mice [76],
suggesting paraoxonase may play a role in defending against
Parkinson etiologic factors. Therefore, in this scenario, the defined
lactonase activity of PON2 may somehow indirectly lead to
reduced oxidative stress, at least under certain conditions. A
second possibility is that the lactonase activity is somehow separate
from the oxidative capacity of PON2. In support of this
hypothesis, it was reported that the antioxidant capacity could
be dissociated from the lactonase activity [77]. It is interesting to
speculate that perhaps PON2 might modify the antioxidant
capacity of DJ-1 directly. However, our studies indicate that
expression of PON2 by itself in the absence of DJ-1 is protective,
suggesting that this is not the case. Resolution of these questions
will be of critical importance in future studies.
A final interesting point is that while both PON2 and DJ-1 have
been localized to numerous subcellular compartments, both have
been associated with mitochondrial functions. For example, DJ-1
accumulates in mitochondria (presumably outer mitochondrial
membrane) in response to oxidant stress [20,78]. DJ-1 may also be
present in more interior mitochondrial compartments [79]. The
role of DJ-1 in mitochondrial functions has not been fully
understood although it has been suggested to be essential for the
survival promoting capacity of DJ-1 [69]. Similarly, PON2 has
also been reported in the mitochondria where it binds to
coenzyme Q10 [27]. In this regard, it has been shown that
PON2 deficient mice have less complex I and III activity and less
ATP production and also elevated mitochondrial ROS generation
[27]. It is therefore interesting to speculate that perhaps DJ-1 may
interact with PON2 in the mitochondria to regulate antioxidant
stress responses. This is an exciting possibility given the increasing
association of mitochondrial defects with the mechanisms under-
lying PD and the number of PD linked genes including DJ-1
associated with mitochondrial quality control [20,78,80]. In
support of this, we have shown that DJ-1 loss leads to increased
ROS production from isolated mitochondria [80]. Whether this
relates to the function of DJ-1 on PON2 will also be of interest in
future studies.
In summary, we demonstrate that DJ-1, a Parkinson’s disease
related gene, interacts with PON2 in neurons and cell lines. This
interaction appear to modulate PON2 activity as DJ-1 KO cells
have less basal PON2 activity and do not respond to oxidative
stress as DJ-1 WT cells do. This effect can be reversed by
expression of DJ-1. In addition, expression of PON2 in DJ-1 KO
neurons is more protective against Parkinson’s model of neuronal
death than expression of DJ-1 in PON2 deficient background.
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